Recent Posts

Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical Trial

Katie Lew · August 29, 2024

August 29, 2024

Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical Trial

Ground-breaking investigational product from Melodi Health is designed to reduce post-surgical infections

August 27, 2024

NeuraWorx Partners with Corundum Neuroscience to Initiate Clinical Feasibility Study, Develop Innovative Neurological Disease Treatment

EXCELSIOR, Minn. – Aug. 27, 2024 – PRLog — NeuraWorx Medical Technologies, Inc., a neurotechnology therapeutics company, announced

August 27, 2024

Biocoat Incorporated Secures New Patent for Non-PFAS Inner Diameter Coating

Horsham, PA, [August 27, 2024] – Biocoat Incorporated, a leader in the

Future Forward: Global Innovation in Medical Alley

Katie Lew

June 11, 2024

Future Forward: Global Innovation in Medical Alley

New Publication Reviewing Percutaneous PNS in the Management of Chronic Pain Highlights Consistent, Sustained Relief of Pain Across Multiple Targets

Tyler Mason

June 11, 2024

New Publication Reviewing Percutaneous PNS in the Management of Chronic Pain Highlights Consistent, Sustained Relief of Pain Across Multiple Targets

In the Know: Healthcare News for June 10, 2024

Tyler Mason

June 7, 2024

In the Know: Healthcare News for June 10, 2024

For the Record with Paul Josephs, President and CEO, Lifecore Biomedical

Tyler Mason

June 7, 2024

For the Record with Paul Josephs, President and CEO, Lifecore Biomedical

Learn more about [your subject]. Start Now!

Click the button to get started!

Success message!

Warning message!

Error message!